Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia Spectrum and Other Psychotic Disorders

Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.

3,091 public trials 348 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Completed

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

NCT00650611

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +5 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Altamonte Springs, Florida, United States
  • Pfizer Investigational Site Libertyville, Illinois, United States
  • Pfizer Investigational Site Lexington, Kentucky, United States
View all 17 locations
View Trial Details
Completed

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

NCT00145444

Conditions
Mental Disorders, Psychotic Disorders, Schizophrenia, +1 more
Locations
  • Pfizer Investigational Site Antwerp, Belgium
  • Pfizer Investigational Site Duffel, Belgium
  • Pfizer Investigational Site Kortenberg, Belgium
  • Pfizer Investigational Site Ermelo, Netherlands
View Trial Details
Completed

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

NCT00136994

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Pfizer Investigational Site Savigliano, Cuneo, Italy
  • Pfizer Investigational Site Campi Bisenzio, Firenze, Italy
  • Pfizer Investigational Site Sora, Frosinone, Italy
  • Pfizer Investigational Site Parma, PR, Italy
View all 34 locations
View Trial Details
Completed

Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

NCT00137020

Conditions
Mental Disorders, Psychotic Disorders, Schizophrenia, +1 more
Locations
  • Pfizer Investigational Site Alexandria, Egypt
  • Pfizer Investigational Site Asyut, Egypt
  • Pfizer Investigational Site Cairo, Egypt
  • Pfizer Investigational Site Tanta, Egypt
View all 27 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

NCT00644800

Conditions
Acute Exacerbation of Psychosis, Delusional Disorder, Mania, +9 more
Locations
  • Pfizer Investigational Site Fortaleza, Ceará, Brazil
  • Pfizer Investigational Site Salvador, Estado de Bahia, Brazil
  • Pfizer Investigational Site Belo Horizonte, Minas Gerais, Brazil
  • Pfizer Investigational Site Curitiba, Paraná, Brazil
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

NCT00645372

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Pfizer Investigational Site Beijing, China
  • Pfizer Investigational Site Beijing, China
  • Pfizer Investigational Site Guangzhou, China
  • Pfizer Investigational Site Nanjing, China
View Trial Details

Related conditions